Isao Asaka

3.0k total citations
28 papers, 1.1k citations indexed

About

Isao Asaka is a scholar working on Molecular Biology, Rheumatology and Immunology. According to data from OpenAlex, Isao Asaka has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 4 papers in Rheumatology and 4 papers in Immunology. Recurrent topics in Isao Asaka's work include Pluripotent Stem Cells Research (10 papers), CRISPR and Genetic Engineering (6 papers) and Ginseng Biological Effects and Applications (5 papers). Isao Asaka is often cited by papers focused on Pluripotent Stem Cells Research (10 papers), CRISPR and Genetic Engineering (6 papers) and Ginseng Biological Effects and Applications (5 papers). Isao Asaka collaborates with scholars based in Japan, United States and Switzerland. Isao Asaka's co-authors include Tatsutoshi Nakahata, Shinya Yamanaka, Akira Watanabe, Megumu K. Saito, Akira Niwa, Masao Hirotani, Tsutomu Furuya, Toshio Heike, Takayuki Tanaka and Masakatsu Sone and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Isao Asaka

27 papers receiving 1.1k citations

Peers

Isao Asaka
Ilka Wappler United Kingdom
Trieu Nguyen United States
Ji-Ung Jung United States
Kunio Ii Japan
Michelle Tang United States
Yi You China
Ilka Wappler United Kingdom
Isao Asaka
Citations per year, relative to Isao Asaka Isao Asaka (= 1×) peers Ilka Wappler

Countries citing papers authored by Isao Asaka

Since Specialization
Citations

This map shows the geographic impact of Isao Asaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isao Asaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isao Asaka more than expected).

Fields of papers citing papers by Isao Asaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isao Asaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isao Asaka. The network helps show where Isao Asaka may publish in the future.

Co-authorship network of co-authors of Isao Asaka

This figure shows the co-authorship network connecting the top 25 collaborators of Isao Asaka. A scholar is included among the top collaborators of Isao Asaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isao Asaka. Isao Asaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aoi, Takashi, Isao Asaka, Hidenori Akutsu, et al.. (2024). Secondary Publication: Proposal for Points of Consideration for Pluripotent Stem Cell Culture. In Vitro Cellular & Developmental Biology - Animal. 60(5). 563–568. 1 indexed citations
2.
Saito, Megumu K., Mitsujiro Osawa, Akira Niwa, et al.. (2023). A disease-specific iPS cell resource for studying rare and intractable diseases. Inflammation and Regeneration. 43(1). 43–43. 8 indexed citations
3.
Awaya, Tomonari, Mami Matsuo‐Takasaki, Miho Takami, et al.. (2021). Generation of two human induced pluripotent stem cell lines derived from two X-linked adrenoleukodystrophy patients with ABCD1 mutations. Stem Cell Research. 53. 102337–102337. 4 indexed citations
4.
Ikeda, Hanako Ohashi, Yumi Inoue, Yuto Iida, et al.. (2021). Deterioration of phagocytosis in induced pluripotent stem cell-derived retinal pigment epithelial cells established from patients with retinitis pigmentosa carrying Mer tyrosine kinase mutations. Experimental Eye Research. 205. 108503–108503. 8 indexed citations
5.
Korogi, Y., Shimpei Gotoh, Satoshi Ikeo, et al.. (2019). In Vitro Disease Modeling of Hermansky-Pudlak Syndrome Type 2 Using Human Induced Pluripotent Stem Cell-Derived Alveolar Organoids. Stem Cell Reports. 12(3). 431–440. 70 indexed citations
6.
Niwa, Akira, Norikazu Saiki, Yuri Kawasaki, et al.. (2018). Pluripotent Stem Cell Model of Nakajo-Nishimura Syndrome Untangles Proinflammatory Pathways Mediated by Oxidative Stress. Stem Cell Reports. 10(6). 1835–1850. 24 indexed citations
7.
Hata, Masayuki, Hanako Ohashi Ikeda, Yuto Iida, et al.. (2018). Reduction of lipid accumulation rescues Bietti’s crystalline dystrophy phenotypes. Proceedings of the National Academy of Sciences. 115(15). 3936–3941. 48 indexed citations
8.
Takada, Sanami, Naotomo Kambe, Yuri Kawasaki, et al.. (2017). Pluripotent stem cell models of Blau syndrome reveal an IFN-γ–dependent inflammatory response in macrophages. Journal of Allergy and Clinical Immunology. 141(1). 339–349.e11. 41 indexed citations
9.
Fujikura, Junji, Michio Noguchi, Kazuhiro Nakao, et al.. (2016). Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations. Metabolism. 65(4). 543–556. 23 indexed citations
10.
Hayashi, Yohei, Edward C. Hsiao, Salma Sami, et al.. (2016). BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence. Proceedings of the National Academy of Sciences. 113(46). 13057–13062. 69 indexed citations
11.
Yasuno, Tetsuhiko, Kenji Osafune, Hidetoshi Sakurai, et al.. (2014). Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency. Biochemical and Biophysical Research Communications. 448(2). 175–181. 39 indexed citations
12.
Matsumoto, Yoshihisa, Yohei Hayashi, Christopher R. Schlieve, et al.. (2013). Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation. Orphanet Journal of Rare Diseases. 8(1). 190–190. 89 indexed citations
13.
Hitomi, Toshiaki, Toshiyuki Habu, Hatasu Kobayashi, et al.. (2013). Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. Biochemical and Biophysical Research Communications. 438(1). 13–19. 94 indexed citations
14.
Hitomi, Toshiaki, Toshiyuki Habu, Hatasu Kobayashi, et al.. (2013). The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality. Biochemical and Biophysical Research Communications. 439(4). 419–426. 48 indexed citations
15.
Yanagimachi, Masakatsu, Akira Niwa, Takayuki Tanaka, et al.. (2013). Robust and Highly-Efficient Differentiation of Functional Monocytic Cells from Human Pluripotent Stem Cells under Serum- and Feeder Cell-Free Conditions. PLoS ONE. 8(4). e59243–e59243. 118 indexed citations
16.
Fujikura, Junji, Kazuwa Nakao, Masakatsu Sone, et al.. (2012). Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation. Diabetologia. 55(6). 1689–1698. 69 indexed citations
17.
Yahata, Naoki, Masashi Asai, Shiho Kitaoka, et al.. (2011). Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease. PLoS ONE. 6(9). e25788–e25788. 141 indexed citations
18.
Asaka, Isao, et al.. (1994). Mass Production of Ginseng (Panax ginseng) Embryoids on Media Containing High Concentrations of Sugar1. Planta Medica. 60(2). 146–148. 13 indexed citations
19.
Asaka, Isao, et al.. (1994). Ginsenoside contents of plantlets regenerated from Panax ginseng embryoids. Phytochemistry. 36(1). 61–63. 9 indexed citations
20.
Asaka, Isao, et al.. (1993). Embryoid Formation by High Temperature Treatment from Multiple Shoots ofPanax ginseng1. Planta Medica. 59(4). 345–346. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026